Palogic Value Fund Withdraws Nominees and Shareholder Proposal at Pebblebrook Hotel Trust
Highlights Persistent Concerns About NAV Accretion, Executive Accountability, and Economic Alignment
Encourages Board to Explore Asset Sales to Accelerate Share Buyback Program or Consider Sale of Company
c/o Corporate Secretary
Dear Members of the Board:
Palogic is highly encouraged by the steps Pebblebrook has recently taken to enhance corporate governance. As we have communicated previously, we believe the persistent discount to Net Asset Value (NAV) has been exacerbated by governance issues, specifically regarding extended Board tenures and the alignment of economic incentives.
The addition of directors
We acknowledge the professionalism shown by
We Continue to Question Pebblebrook’s NAV Accretion Narrative and Have Significant Capital Allocation Concerns
While we applaud these governance changes, Palogic retains significant concerns regarding the pursuit of NAV accretion, executive accountability, and economic alignment.
Since highlighting the discount to NAV in 2021, the Company has reduced the share count by approximately 14% over a four-year period. With a de minimis cash payout of
Our concerns regarding NAV pursuit remain, and we are hopeful that the refreshed Board will make the following questions a centerpiece of the ongoing strategic discussion and communicate a timely framework to address them:
- Why does the NAV gap exist?
- If NAV accretion is a key priority, why is management not more aggressively pursuing a strategy of acquiring shares?
- What assets could be readily sold to accelerate NAV accretion?
- Would shareholders benefit more from a sale of the entire Company to provide certainty and realize NAV?
The episodic nature of Pebblebrook’s previous buybacks suggests to the market that the Company lacks the financial capacity to pursue NAV accretion without prior deleveraging. Our research indicates deep institutional demand for
To maximize value, the Board must accept that it is difficult to serve "two masters." Prioritizing traditional REIT metrics like FFO and FFO growth may need to be secondary to the massive accretion available by purchasing shares at an approximate 50% discount to NAV.
Additionally, while we acknowledge the intangible benefits that come from exiting a market like
We Encourage a Review of Executive Compensation Structure
We also remain concerned by the concentration of decision-making power among Chairman and Chief Executive Officer
-
Mr. Bortz’s total compensation since Pebblebrook went public is
$83.7 million through 2024. -
Mr. Martz andMr. Fisher have each been compensated close to$40 million through 2024.1
In our opinion, it is difficult for unaffiliated shareholders to maintain confidence when management is afforded a compensation structure that has not translated into value for the owners of the Company. Despite the approximate 50% NAV discount, we have observed very limited insider buying outside of purchases by
We encourage the Board to review the existing compensation structure to ensure that management is not being incentivized with deeply discounted shares at the expense of unaffiliated shareholders.
Looking Ahead
Given the persistent concerns raised above, we wonder if Pebblebrook’s strategy – focused on full-service, high-barrier to entry coastal markets – would ultimately be better suited for a buyer with a lower cost of capital. The public hotel REIT space has been unforgiving. The corporate strategy may just not align with the current desires of the public markets for portfolios with significantly higher EBITDA margins and less cyclicality, a more consistent corporate theme (e.g., convention/entertainment), or operational leverage and deep relationships with specific brands as the building blocks for value creation. As such, we encourage the Board to consider the sale of the entire Company.
We look forward to seeing how the refreshed Board will challenge the status quo and accelerate the realization of shareholder value.
Respectfully,
Scott Williams, Principal
About Palogic
| ____________________ | ||
|
(1) |
Total compensation as disclosed in Pebblebrook’s Annual Proxy Statements from the years 2009 to 2025 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260217223731/en/
Investor Contact
pr@palogicfund.com
Media Contact
August
Palogic-August@AugustCo.com
Source: